CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FierceBiotech
Original article

{"a":[{"_":"Craif raises $33M to boost work on its urine test for cancer ","$":{"href":"/medtech/craif-raises-33m-boost-work-its-urine-test-cancer","hreflang":"en"}}]}

urine test for cancerPositive
AI Analysis

Summary

Craif raised $33 million in Series D funding to advance its AI-powered urine test for cancer detection, bringing total capital raised to $88 million. The company also announced a new executive addition.

Importance:4/10
Sentiment:
0.60
fundingSeries Dcancer diagnosticsAI/machine learningurine test

Read the original article

Published by FierceBiotech on August 18, 2026 8:14 AM

Read Original